EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Effects of Sesamin in Animal Models of Obesity-Associated Diseases: A Systematic Review and Meta-Analysis

Jinshi Zuo, Jingyi Ren, Bowen Yin, Ziyi Wang, Qiqi Cui, Jiarui Liu, Dan Huang, Huanting Pei, Rui Wen, Yadong Zhang, Yuxia Ma iD

Nutrition Reviews · 2025

DOI: 10.1093/nutrit/nuae089 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition Reviews, 2025. Verfasst von Jinshi Zuo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Hebei Medical University, Hebei Key Laboratory of Environment and Human Health, Sh…. Hauptthemen laut MEDLINE: Lignans, Obesity, Dioxoles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hebei Medical University, Undergraduate Innovation Experiment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

As living standards have improved and lifestyles have undergone changes, metabolic diseases associated with obesity have become increasingly prevalent. It is well established that sesamin (Ses) (PubChem CID: 72307), the primary lignans in sesame seeds and sesame oil, possess antioxidant and anti-inflammatory effects.

Objective

In this study, a systematic review and meta-analysis of the effects of Ses on animal models of obesity-related diseases was performed to assess their impact on relevant disease parameters. Importantly, this study sought to provide insights for the design of future human clinical studies utilizing Ses as a nutritional supplement or drug. Data Sources This study conducted a comprehensive search in PubMed, Web of Science, Embase, Scopus, and the Cochrane Library, identifying English language articles published from inception to April 2023. Data Extraction The search incorporated keywords such as “sesamin,” “obesity,” “non-alcoholic fatty liver disease,” “type 2 diabetes mellitus,” and “metabolic syndrome.” The meta-analysis included 17 articles on non-alcoholic fatty liver disease, type 2 diabetes, and metabolic syndrome. Data Analysis Overall, the pooled results demonstrated that Ses significantly reduced levels of total serum cholesterol (P = .010), total serum triglycerides (P = .003), alanine transaminase (P = .003), and blood glucose (P < .001), and increased high-density lipoprotein cholesterol levels (P = .012) in animal models of nonalcoholic fatty liver disease. In the type 2 diabetes model, Ses mitigated drug-induced weight loss (P < .001), high-fat-diet–induced weight gain (P < .001), and blood glucose levels (P = .001). In the metabolic syndrome model, Ses was associated with a significant reduction in body weight (P < .001), total serum cholesterol (P < .001), total serum triglycerides (P < .001), blood glucose (P < .001), and alanine transaminase levels (P = .039).

Conclusion

The meta-analysis results of this study suggest that Ses supplementation yields favorable effects in animal models of obesity-related diseases, including hypolipidemic, insulin-lowering, and hypoglycemic abilities, as well as organ protection from oxidative stress and reduced inflammation. Systematic Review Registration PROSPERO registration No. CRD42023438502.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansObesityDioxolesAnimalsDisease Models, AnimalNon-alcoholic Fatty Liver DiseaseMetabolic SyndromeDiabetes Mellitus, Type 2Dietary SupplementsHumansAntioxidants

Stichwörter der Autor:innen

meta-analysismetabolic syndromenon-alcoholic fatty liver diseaseobesitysesamintype 2 diabetes

Substanzen

LignanssesaminDioxolesAntioxidants

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, School of Public Health, Hebei Medical University, Hebei Key Laboratory of Environment and Human Health, Shijiazhuang, 050017, China.
  • Undergraduate of College of Public Health, Hebei Medical University, Shijiazhuang, 050017, China.
  • Undergraduate of College of Basic Medicine, Hebei Medical University, Shijiazhuang, 050017, China.

ORCID-Profile: Yuxia Ma

Förderung

  • National Natural Science Foundation of China
  • Hebei Medical University
  • Undergraduate Innovation Experiment

Zitieren

APA

Zuo, J., Ren, J., Yin, B., Wang, Z., Cui, Q., Liu, J., Huang, D., Pei, H., Wen, R., Zhang, Y., & Ma, Y. (2025). Effects of Sesamin in Animal Models of Obesity-Associated Diseases: A Systematic Review and Meta-Analysis. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuae089

Vancouver

Zuo J, Ren J, Yin B, Wang Z, Cui Q, Liu J, et al. Effects of Sesamin in Animal Models of Obesity-Associated Diseases: A Systematic Review and Meta-Analysis. Nutrition Reviews. 2025. doi:10.1093/nutrit/nuae089

BibTeX
@article{Zuo2025,
  author = {Zuo, Jinshi and Ren, Jingyi and Yin, Bowen and Wang, Ziyi and Cui, Qiqi and Liu, Jiarui and Huang, Dan and Pei, Huanting and Wen, Rui and Zhang, Yadong and Ma, Yuxia},
  title = {Effects of Sesamin in Animal Models of Obesity-Associated Diseases: A Systematic Review and Meta-Analysis},
  journal = {Nutrition Reviews},
  year = {2025},
  doi = {10.1093/nutrit/nuae089}
}
Kostenlos starten →